Nobiletin protected against hypertrophic cardiomyopathy via targeting PPARα
BackgroundHypertrophic cardiomyopathy is an independent risk factor for heart failure. Citrus reticulata (C. reticulata) is a traditional Chinese medicine with a variety of chemical components and pharmacological effects. The mechanisms of C. reticulata for treating hypertrophic cardiomyopathy are s...
Saved in:
| Main Authors: | Kewei Zhou, Chang Chen, Hexin Cai, Zuqian Lian, Luping Wang, Qinghuo Li, Cancan Wang, Xiaoqian Wu, Panxia Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1628625/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Citrus flavonoids for overcoming breast cancer resistance to methotrexate: identification of potential targets of nobiletin and sinensetin
by: Adam Hermawan, et al.
Published: (2025-03-01) -
Hypertrophic Cardiomyopathy: Genes and Mechanisms
by: Jinli Chen, et al.
Published: (2025-02-01) -
Nobiletin Regulates Lysosome Function in Bovine Endometrial Epithelial Cells
by: Karen Koshimizu, et al.
Published: (2024-11-01) -
INFECTIVE ENDOCARDITIS IN THE PRESENCE OF HYPERTROPHIC CARDIOMYOPATHY
by: E. Yu. Ponomareva
Published: (2014-07-01) -
Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021-09-01)